Related references
Note: Only part of the references are listed.Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis
Tatiana Y. Hargrove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Biology and pathogenesis of Naegleria fowleri
Ruqaiyyah Siddiqui et al.
ACTA TROPICA (2016)
Structural Insights into Binding of the Antifungal Drug Fluconazole to Saccharomyces cerevisiae Lanosterol 14 alpha-Demethylase
Alia A. Sagatova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis
S. T. de Macedo-Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Structure-Functional Characterization of Cytochrome P450 Sterol 14α-Demethylase (CYP51B) from Aspergillus fumigatus and Molecular Basis for the Development of Antifungal Drugs
Tatiana Y. Hargrove et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Successful Treatment of an Adolescent With Naegleria fowleri Primary Amebic Meningoencephalitis
W. Matthew Linam et al.
PEDIATRICS (2015)
Genome-wide identification of pathogenicity factors of the free-living amoeba Naegleria fowleri
Denise C. Zysset-Burri et al.
BMC GENOMICS (2014)
Expanding the Binding Envelope of CYP51 Inhibitors Targeting Trypanosoma cruzi with 4-Aminopyridyl-Based Sulfonamide Derivatives
Debora F. Vieira et al.
CHEMBIOCHEM (2014)
Drug Strategies Targeting CYP51 in Neglected Tropical Diseases
Jun Yong Choi et al.
CHEMICAL REVIEWS (2014)
Tissue Penetration of Antifungal Agents
Timothy Felton et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51
Debora F. Vieira et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency
Claudia M. Calvet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Novel cathepsin B and cathepsin B-like cysteine protease of Naegleria fowleri excretory-secretory proteins and their biochemical properties
Jinyoung Lee et al.
PARASITOLOGY RESEARCH (2014)
Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer
Brian C. Monk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
Carolina B. Moraes et al.
SCIENTIFIC REPORTS (2014)
Dictyostelium Lipid Droplets Host Novel Proteins
Xiaoli Du et al.
EUKARYOTIC CELL (2013)
Correlation of hydrotropic solubilization by urea with logD of drug molecules and utilization of this effect for topical formulations
Michael E. Herbig et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Corifungin, a New Drug Lead against Naegleria, Identified from a High-Throughput Screen
Anjan Debnath et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Novel sterol metabolic network of Trypanosoma brucei procyclic and bloodstream forms
Craigen R. Nes et al.
BIOCHEMICAL JOURNAL (2012)
Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi
Phercyles Veiga-Santos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
A high-throughput drug screen for Entamoeba histolytica identifies a new lead and target
Anjan Debnath et al.
NATURE MEDICINE (2012)
Spectroscopic features of cytochrome P450 reaction intermediates
Abhinav Luthra et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Origin and evolution of the worldwide distributed pathogenic amoeboflagellate Naegleria fowleri
Johan F. De Jonckheere
INFECTION GENETICS AND EVOLUTION (2011)
Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis
A. Calcagno et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
A Nonazole CYP51 Inhibitor Cures Chagas' Disease in a Mouse Model of Acute Infection
Patricia S. Doyle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Structural Basis of Human CYP51 Inhibition by Antifungal Azoles
Natallia Strushkevich et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
Chiung-Kuang Chen et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Phylogenomics of Sterol Synthesis: Insights into the Origin, Evolution, and Diversity of a Key Eukaryotic Feature
Elie Desmond et al.
GENOME BIOLOGY AND EVOLUTION (2009)
Posaconazole concentrations in the central nervous system
Maria J. G. T. Rueping et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
A system for LogD screening of 96-well plates using a water-plug aspiration/injection method combined with high-performance liquid chromatography-mass Spectrometry
Yukifumi Dohta et al.
ANALYTICAL CHEMISTRY (2007)
Comparison of itraconazole and fluconazole treatments in a murine model of coccidioidal meningitis
Perparim Kamberi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The Buccaneer software for automated model building.: 1.: Tracing protein chains
Kevin Cowtan
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2006)
In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas:: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri
FL Schuster et al.
JOURNAL OF EUKARYOTIC MICROBIOLOGY (2006)
Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman
Thomas Elter et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits
AH Groll et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Activity of posaconazole in the treatment of central nervous system fungal infections
P Pitisuttithum et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Amphotericin B
A Lemke et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2005)
Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole
HM Al-Abdely et al.
MEDICAL MYCOLOGY (2005)
Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous Amphotericin B, Fluconazole and rifampicin
J Vargas-Zepeda et al.
ARCHIVES OF MEDICAL RESEARCH (2005)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Crystallization of cytochromes P450 and substrate-enzyme interactions
HY Li et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Evidence for multiple sterol methyl transferase pathways in Pneumocystis carinii
WX Zhou et al.
LIPIDS (2002)
Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection
RR Haynes et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
ElogDoct:: A tool for lipophilicity determination in drug discovery.: 2.: Basic and neutral compounds
F Lombardo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system
AH Groll et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Comparison of fluconazole and itraconazole in a rabbit model of coccidioidal meningitis
KN Sorensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Meningitis caused by Pseudallescheria boydii treated with voriconazole
G Poza et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
